ZeroHedge News
Follow
Supreme Court Rejects Trump Bid To End Hormone Treatments For Transgender Federal Inmates
On October 21, the Supreme Court refused to allow the Trump administration to immediately implement a policy restricting transgender treatments in federal prisons. The Court's unsigned order in Trump v. Kingdom did not provide an explanation for its decision, though Justices Thomas and Alito dissented without comment. The Trump administration had sought to pause a nationwide injunction compelling the Bureau of Prisons (BOP) to continue providing hormone treatments and related services to inmates diagnosed with gender dysphoria. Solicitor General D. John Sauer filed an emergency application to halt a federal district judge's order blocking BOP policy Program Statement 5260.01. This policy aimed to end transgender surgeries, hormone treatments, and social accommodations in prisons, which the government argued were vital for security. The lead plaintiff in the underlying class action is Alishea Sophia Kingdom, a man identifying as female. U.S. District Judge Royce Lamberth had blocked the policy in June, deeming it "arbitrary and capricious agency action" likely to violate the Administrative Procedure Act. Lamberth ordered the BOP to continue providing treatments and accommodations to inmates with a gender dysphoria diagnosis. A D.C. Circuit Court of Appeals panel subsequently declined to stay Lamberth's order. Sauer contended that Lamberth's ruling denied prison administrators due deference and interfered with their expert judgment in managing federal prisons.